Japan· JP-2492424G2029
インスリン イコデク（遺伝子組換え）
A medicinal product containing インスリン イコデク（遺伝子組換え）, registered in Japan by ノボ ノルディスク ファーマ, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- インスリン イコデク（遺伝子組換え）
- Manufacturer
- ノボ ノルディスク ファーマ
- Country
- Japan (JP)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
インスリン イコデク（遺伝子組換え） in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaAWIQLINovo Nordisk A/S, Bagsvaerd
- BelgiumAwiqli 700 U/mlNovo Nordisk
- SwitzerlandAwiqli FlexTouch 700 E/ml, Injektionslösung im FertigpenNovo Nordisk Pharma AG
- United StatesAwiqliNovo Nordisk Pharmaceutical Industries, LP
- CanadaAWIQLINOVO NORDISK CANADA INC
- ItalyAWIQLI*1 penna preriempita SC 700 U/ml 1,5 ml + 14 aghiNOVO NORDISK A/S
- IrelandAwiqli 700 units/mL solution for injection in pre-filled penNovo Nordisk A/S
- IcelandAwiqliNovo Nordisk A/S*
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Awiqli
- Norway · Awiqli
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/65c25a64-debb-407b-90fa-92fe087f7b48 GET /v1/drugs/65c25a64-debb-407b-90fa-92fe087f7b48?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "７００単位１キット",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "2492424G2029",
"category": "注射薬",
"price_yen": 3809,
"generic_name": "インスリン イコデク（遺伝子組換え）",
"product_name_jp": null,
"therapeutic_class": "2492",
"transitional_expiry": null
}See everything about インスリン イコデク（遺伝子組換え）.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.